HanchorBio Announces US IND Clearance for the Multi-Regional Clinical Trial of HCB101 to Treat Solid and Hematological Malignancies HanchorBio Received IND Clearance of HCB101 Multi-regional Clinical Trial By US FDA TAIPEI, TAIWAN and SAN FRANCISCO, ...
